ICON

ICON Announces Appointment of New Chief Financial Officer

DUBLIN – ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced the appointment of Nigel Clerkin as its new Chief Financial Officer (CFO). Nigel brings extensive experience and capability to the role of CFO. He commenced his career with KPMG, before joining Elan Corporation where he held a number of roles of increasing responsibility over a fifteen-year career, culminating in the … Continue reading ICON Announces Appointment of New Chief Financial Officer

Bio X Cell

Bio X Cell Announces CEO Appointment

News provided by Bio X Cell 12 Aug, 2024, 06:00 GMT A Leading Producer of Monoclonal Antibodies LEBANON, N.H., Aug. 12, 2024 /PRNewswire/ — Bio X Cell, LLC (“BXC” or the “Company”), a leading producer of monoclonal antibodies for pre-clinical in vivo research applications, is pleased to announce the appointment of Christopher Conway as Chief Executive Officer. Mr. Conway has extensive experience in both small molecule and Biologics drug discovery, most … Continue reading Bio X Cell Announces CEO Appointment

Agenus

Agenus Announces Appointment of Tom Harrison to Board of Directors

Advertising Veteran Tapped to Elevate Awareness of Agenus and Its Innovative Pipeline LEXINGTON, Mass. – Agenus Inc. (NASDAQ: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced the appointment of Tom Harrison to its Board of Directors. Mr. Harrison brings a wealth of experience and a proven track record in healthcare advertising, branding, and strategic advising. “Tom’s extensive … Continue reading Agenus Announces Appointment of Tom Harrison to Board of Directors

Parse Biosciences

Parse Biosciences Partners with Taiwan-based Prisma Biotech to Extend Reach in Asia

Partnership extends access in Asia to Parse’s growing single cell portfolio SEATTLE – Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Taipei-based Prisma Biotech to broaden Parse’s reach in Taiwan and across Asia-Pacific. “We’re excited to empower them to easily take advantage of Parse’s single cell sequencing technology through our partnership with Prisma.” Post this “Biotech, pharma, … Continue reading Parse Biosciences Partners with Taiwan-based Prisma Biotech to Extend Reach in Asia

Bifrost Biosystems

Bifrost Biosystems Appoints Industry Veteran Jonas Jarvius, PhD as CEO

CAMBRIDGE, Mass – Bifrost Biosystems, a pioneer in Optical Pooled Screening (OPS) technologies, today announced the appointment of experienced life sciences industry executive, Jonas Jarvius, PhD, as Chief Executive Officer, President and Director. He brings to Bifrost over 15 years of C-level executive experience from both private and public companies translating innovative technologies into commercial products that impact human health outcomes. “In my career, I … Continue reading Bifrost Biosystems Appoints Industry Veteran Jonas Jarvius, PhD as CEO